| Literature DB >> 32719669 |
Ying Zhang1,2, Mengfei Chen1,2, Pengfei Yu1,2, Shubo Yu2, Juan Wang3, Hui Guo1,2, Junhui Zhang1,2, Huan Zhou1,2, Moutong Chen2, Haiyan Zeng2, Shi Wu2, Rui Pang2, Qinghua Ye2, Liang Xue2, Shuhong Zhang2, Ying Li2, Jumei Zhang2, Qingping Wu2, Yu Ding1,2.
Abstract
Bacillus cereus is one of the most important foodborne pathogenic microorganisms, which can lead to gastrointestinal and non-gastrointestinal diseases. However, the potential risk of B. cereus in aquatic products in China has not been comprehensively evaluated yet. In this study, a total of 860 aquatic samples from three types of retail aquatic products were collected from 39 major cities in China from 2011 to 2016. The contamination, distribution of virulence genes, antibiotic resistance and genetic diversity of B. cereus isolates were measured and analyzed. Of all the samples, 219 (25.47%) were positive for B. cereus and 1.83% (4/219) of the samples had contamination levels of more than 1,100 most probable number (MPN)/g. Different isolates had virulence potential, within which 59.6% (164/275) contained all three kinds of enterotoxin genes (nhe, hbl, and cytK-2) and 5.1% (14/275) possessed cereulide encoding gene cesB. The antimicrobial resistance profiles revealed the universal antibiotic resistance to rifampin and most β-lactams, suggesting the necessity to continuously monitor the antibiotic resistance of B. cereus in aquatic products and to control drug use in aquaculture. In sum, our study indicates the potential hazards of B. cereus isolated from aquatic products to customers and may provide a reference for clinical treatment caused by B. cereus.Entities:
Keywords: Bacillus cereus; MLST; aquatic products; multi-drug resistance; prevalence
Year: 2020 PMID: 32719669 PMCID: PMC7347965 DOI: 10.3389/fmicb.2020.01513
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Prevalence and contamination level of B. cereus isolated from aquatic products.
| Type | Prevalence rate (%)a | MPN value (MPN/g)b | ||
| MPN < 3 (%) | 3 ≤ MPN < 1100 (%) | 1100 ≤ MPN (%) | ||
| Finfish | 134/523 (25.62) | 28/134 (20.90) | 102/134 (76.12) | 4/134 (2.99) |
| Mollusks | 45/193 (23.32) | 10/45 (22.22) | 35/45 (77.78) | 0/45 (0.00) |
| Crustaceans | 40/144 (27.78) | 3/40 (7.50) | 37/40 (92.50) | 0/40 (0.00) |
| Total | 219/860 (25.47) | 41/219 (18.72) | 174/219 (79.45) | 4/219 (1.83) |
FIGURE 1Detection rate of virulence genes in B. cereus from aquatic products. The gray bars of different heights represent the positive rate of hblA, hblC, hblD, nheA, nheB, nheC, cytK-2 and cesB in B. cereus isolates, respectively. The dark bars indicate the positive rate of hbl gene cluster (hblA, hblC, and hblD), or nhe gene group (nheA, nheB, and nheC), or all eight virulence genes.
Characteristics of cesB-positive isolates.
| Strain | Growth at 7°C | Growth at 43°C | M | P | Source | Region |
| 875 | − | + | + | + | Finfish | E |
| 2039-1 | − | + | + | + | Finfish | E |
| 2078 | − | + | + | + | Crustaceans | N |
| 2827-2A | − | + | + | + | Finfish | C |
| 2829-1A | − | + | + | + | Crustaceans | C |
| 2829-2A | − | + | + | + | Finfish | C |
| 2931-1A | − | + | + | + | Finfish | SW |
| 3626-1B | − | + | + | + | Finfish | SW |
| 3629-1B | − | + | + | + | Mollusks | SW |
| 3631 | − | + | + | + | Finfish | SW |
| 3726-3A | − | + | + | + | Finfish | E |
| 3729-2C | − | + | + | + | Mollusks | E |
| 3831-1A | − | + | + | + | Finfish | NE |
| 3927-1C | − | + | + | + | Finfish | C |
| ATCC14579 | − | + | + | + | − | − |
| F4810/72 | − | + | + | + | − | − |
FIGURE 2Antimicrobial characteristics of B. cereus from aquatic products. The blue, red, and green bars represent the proportion of resistant, intermediate resistant, and sensitive strains, respectively. The light gray, gray, and black bars show the proportion of strains with multidrug resistance (MDR) to at least three, four, and five classes of antibiotics, respectively. AMP, ampicillin (10 μg); P, penicillin (10 units); AMC, amoxicillin-clavulanic acid (20 μg/10 μg); KF, cephalothin (30 μg); FOX, cefoxitin (30 μg); RD, rifampin (5 μg); DA, clindamycin (2 μg); QD, quinupristin-dalfopristin (15 μg); E, erythromycin (15 μg); FD, nitrofurantoin (300 μg); TE, tetracycline (30 μg); CTT, cefotetan (30 μg); SXT, trimethoprim-sulfamethoxazole (1.25 μg/23.75 μg); TEL, telithromycin (15 μg); TEC, teicoplanin (30 μg); CIP, ciprofloxacin (5 μg); K, kanamycin (30 μg); C, chloramphenicol (30 μg); CN, gentamicin (10 μg); IPM, imipenem (10 μg).
FIGURE 3Minimum spanning tree and genetic diversity of 275 B. cereus isolates from aquatic products. Each color represents one clonal complex or a group of singletons. The numbers inside the pie chart are the corresponding sequence types (STs), and the size of the pie chart is proportional to the number of isolates in the corresponding ST. The number along the line indicates the variation of the seven loci between two strains at both ends of the line.